Clinical Lipidology: A Companion to Braunwald’s Heart Disease, 3rd edition

Clinical Lipidology: A Companion to Braunwald’s Heart Disease, 3rd edition

12 $

Format : True PDF (No ToC & Index)

File Size : 26.8 MB

Category:

Clinical Lipidology: A Companion to Braunwald’s Heart Disease, 3rd edition

 

By Christie M. Ballantyne MD FACP FACC

Clinical Lipidology: A Companion to Braunwald’s Heart Disease, written by Christie M. Ballantyne MD FACP FACC, is an essential guide for clinicians in the management of patients with high cholesterol levels and other atherogenic lipid disorders. This book offers extensive coverage on lipidology with concise, clear, and authoritative guidance on all aspects of the management of lipid disorders. The third edition of the book has been updated with new chapters, algorithms, and case studies.

This comprehensive guidebook is an invaluable resource for cardiologists, lipidologists, endocrinologists, and internal medicine physicians. The book starts with basic science and pathogenesis of atherothrombotic disease, followed by risk assessment, therapy options, and emerging platforms in the field of lipidology. It is packed with the latest research-based recommendations and therapeutic breakthroughs that will guide clinicians on how to assess, diagnose, and treat patients with high levels of lipids and lipoproteins.

One significant feature of this book is its accessibility and user-friendly manner, with condensed and streamlined content that highlights clinical applications and concepts that clinicians can apply in their practice. The chapters have been reorganized into four main sections, namely; risk assessment, therapy, emerging therapeutic targets and platforms, and special populations. The book is presented in a concise and easy-to-read format with treatment algorithms throughout, along with case studies that highlight the most common clinical questions in each chapter.

The book’s third edition includes several new chapters that cover emerging therapeutic targets such as Polygenic Risk Scores, Inclisiran, Bempedoic Acid, and Pemafibrate, among others. Additionally, new or expanded content on inflammation, genetic testing, statins, and the role of bile acid sequestrants, niacin, and fibrates, mAbs, CANTOS and CIRT, colchicine, IL-6, and cellular, molecular, and genetic therapy have also been added.

The book is up to date with the latest guidelines from the AHA, ACC, ESC, and EAS, and it provides future directions for ongoing research and emerging applications in the fields of lipidology.

In conclusion, Clinical Lipidology: A Companion to Braunwald’s Heart Disease is a must-have book for clinicians in the field of lipidology. It is written in an accessible and user-friendly manner, providing clinicians with authoritative guidance on the therapeutic management of patients with high cholesterol levels and other atherogenic lipid disorders. The book covers all the latest research-based recommendations, therapeutic breakthroughs, and related clinical advances, making it an invaluable resource for anyone with an interest in lipidology. Order your copy today and discover why this book is so highly regarded in the field!

Product Details

  • Thoroughly covers the assessment, diagnosis, and treatment of patients with elevated levels of lipids and lipoproteins, including all the latest research-based recommendations, therapeutic breakthroughs, and related clinical advances.
  • Presents the latest data on clinical guidelines, risk assessments, and established and emerging pharmacologic and nonpharmacologic therapies―all from internationally recognized experts in the field.
  • Features condensed, streamlined content that focuses on clinical applications and applying concepts to the practice setting. Chapters have now been completely reorganized into sections on risk assessment; therapy; new and evolving therapeutic targets and platforms; and special populations.
  • Includes new chapters on Polygenic Risk Scores; Inclisiran; Bempedoic Acid; Selective Peroxisome Proliferator–Activated Receptor–a Modulator: Pemafibrate; Evolving Therapeutic Targets: Lp(a), ANGPTL3, and ApoC-III; New Therapeutic Platforms: Gene Therapy and Genome Editing; and more.
  • Contains new or expanded content on inflammation; genetic testing; troponins for risk assessment; statins and role of bile acid sequestrants, niacin, and fibrates; mAbs; CANTOS and CIRT; colchicine; IL-6; and cellular, molecular, and genetic therapy.
  • Provides treatment algorithms throughout, as well as case vignettes that highlight the most common clinical questions in each chapter.
  • Incorporates the latest guidelines from the AHA, ACC, ESC, and EAS, as well as future directions for ongoing research and emerging applications.
  • Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
  • Publisher ‏ : ‎ Elsevier; 3rd edition (May 3, 2023)
  • Language ‏ : ‎ English
  • Hardcover ‏ : ‎ 432 pages
  • ISBN-10 ‏ : ‎ 0323882862
  • ISBN-13 ‏ : ‎ 978-0323882866

Related Products